|
COPYRIGHT 2006 Business Wire
DENVER -- Myogen, Inc. (Nasdaq:MYOG), a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular disorders, today announced that J. William Freytag, President and CEO, will present a corporate overview at the Citigroup Small & Mid-Cap Conference to be held...
Read the full article for free courtesy of your local library.
|